A Phase 2, Proof of Concept, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination on Atrial Fibrillation Burden in Subjects With Paroxysmal Atrial Fibrillation.

Trial Profile

A Phase 2, Proof of Concept, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination on Atrial Fibrillation Burden in Subjects With Paroxysmal Atrial Fibrillation.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Dronedarone/ranolazine (Primary) ; Dronedarone; Ranolazine
  • Indications Paroxysmal atrial fibrillation
  • Focus Proof of concept; Therapeutic Use
  • Acronyms HARMONY
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 26 May 2014 Status changed from active, no longer recruiting to completed, according to a Gilead Sciences media release.
    • 10 May 2014 Results were presented during a late-breaking clinical trials session at the annual meeting of the Heart Rhythm Society and reported in a Gilead Sciences media release.
    • 27 Jan 2014 New source identified and integrated; United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top